23rd American Pharma and Biotech Project, Program and Portfolio Management Conference
International in-person conference filled with leading industry speakers.
key information
- Location: Boston, MA, United States
- October 16-18, 2024
- 8:30 - 17:30 Local Time
OUR CONFERENCE PROGRAM
This is not just another PPM conference. This is a conference which tells you a STORY. One story, followed by another, stories of exceptional people who happen to choose Project and Portfolio Management as their way to bring needed medicines to improve the health of millions of people on our planet. Our conference will feature numerous assisted networking sessions which will help you create those critical business friendships needed for fruitful cooperation with professionals from the industry for many years to come. We believe, that our thoughtfully planned conference will fill in any missing pieces in your
plans on the mission to deliver your projects faster, more efficiently and with ease and satisfaction.
Main Takeaways
- Creating Alignment between Strategy, Capabilities, and Project Portfolios
- Balancing Short-Term and Long-Term Goals in Portfolio Planning
- Approaches to Risk Management and Mitigation
- Managing PPM for Clinical Trials
- Unlocking the Power of AI/ML in Project Management
- Increasing Transparency and Simplicity in Project Portfolio Management
Testimonials
- 38% CXO, MD, Chairman, President, VP, Executive Director & General Manager
- 27% Senior Patient Experience/Relations Management & Service Excellence Executives
- 20% Administration & Quality assurance management
- 15% Others: Nursing management, Clinicians, data management, pharmacy directors
Event Speakers
Sabine Pfeffer
Novartis
Larry Picket
Syneos Health
Jörn Lenz
Medac
Gerrit Buurman
Bachem
Mithun Mridha
Capgemini
Florian Ivan
PMI, ROLF
Stephen Cho
Novartis
Jana Vranova
Biogen
Bence Tüske
Sanofi
Maciej Szymaszek
AstraZeneca
Ulrike Grimm
Opterion Health AG
Rosa Arienzo
LifeArc
Stefanie Amend-Mall
Sandoz
Jan Laschinger
Heads
Daria Mikhailova
Novartis Institutes for BioMedical Research
Martin Braun
Lonza
Kamil Mroz
UCB
Stephan Aufhammer
Stada
REGISTRATION
At our conference, we want to ensure that everyone can attend in a way that fits their schedule. That’s why we’ve created five different registration ticket options. Whether you can only join us for a two days, or you want to attend the entire conference, we’ve got you covered.
No matter which registration option you choose, you’ll enjoy refreshments, snacks, and sit down lunches during the conference or masterclass. You’ll also have access to all of our networking activities and materials.
We understand that everyone has different needs and preferences, so we’ve designed these registration tickets to be as flexible as possible. Whether you’re a busy executive who can only attend for a few hours or a dedicated industry professional who wants to immerse themselves in the conference, we’ve got a ticket that’s perfect for you.
2 DAY CONFERENCE
REGISTRATION-
Can't attend all three days of the conference? Register for this ticket and choose to attend any two of three days.
Masterclass
REGISTRATION-
Enjoy industry veteran Dr. Richard Bayney's masterclass, only!
MASTERCLASS +
2 DAY CONFERENCE
REGISTRATION
-
Experience the Masterclass with renowned industry veteran Dr. Richard Bayney as well as any two of three days of the conference.
MASTERCLASS +
3 DAY CONFERENCE
REGISTRATION
-
The Full Package - experience the masterclass with Richard Bayney as well as all three days of the conference.
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
event partners
GOLD PARTNER
Founded in 2017, Intelligencia AI™ is at the forefront of using data science and artificial intelligence (AI) to address significant challenges in the pharmaceutical industry: extremely long drug development timelines, sky-high costs, and unsustainable ROI. Its suite of AI-powered solutions is built on expertly curated scientific and clinical data. The solutions provide actionable insights that help de-risk drug development by providing an accurate, unbiased assessment of a drug’s probability of success at critical points in the drug development process.
Intelligencia AI is headquartered in New York, NY, with offices in San Francisco, CA, and Athens, Greece, and employs 110 individuals globally. Visit intelligencia.ai to discover more.
GOLD PARTNER
Planisware is a global provider of software solutions for project portfolio management. Planisware solutions are specifically designed to support product development, engineering and IT business processes. For more than 20 years, Planisware has been helping its customers to achieve strategic and innovative excellence, make valid business decisions and increase portfolio value. Today, over 500 companies worldwide rely on Planisware products to manage their projects, resources and portfolios.
STRATEGIC PARTNER
Captario is a software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures. A team can compare options and gain new insights regarding trade-offs between time, cost, risk and value. The approach has consistently led drug project and portfolio teams to substantially increase the overall value. Captario SUM sets a new gold standard for strategic decision making in drug development. Ultimately, this leads to better and more affordable medicines to patients in need.